
Company valuation, historical trends, and peer comparisons.
According to Sumitomo Pharma Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.01T. This represents a change of 10.76% compared to the average of 911.93B of the last 4 quarters.
The mean historical Enterprise Value of Sumitomo Pharma Co., Ltd. over the last ten years is 715.10B. The current 1.01T Enterprise Value has changed 41.24% with respect to the historical average. Over the past ten years (40 quarters), SMDPY's Enterprise Value was at its highest in in the December 2018 quarter at 1.28T. The Enterprise Value was at its lowest in in the December 2022 quarter at 380.84B.
Average
715.10B
Median
652.74B
Minimum
524.70B
Maximum
997.45B
Discovering the peaks and valleys of Sumitomo Pharma Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 71.75%
Maximum Annual Enterprise Value = 997.45B
Minimum Annual Increase = -34.90%
Minimum Annual Enterprise Value = 524.70B
| Year | Enterprise Value | Change |
|---|---|---|
| 2026 | 997.45B | 71.75% |
| 2025 | 580.75B | 3.68% |
| 2024 | 560.12B | 6.75% |
| 2023 | 524.70B | -6.55% |
| 2022 | 561.49B | -34.90% |
| 2021 | 862.57B | 11.88% |
| 2020 | 770.96B | -21.93% |
| 2019 | 987.46B | 61.71% |
| 2018 | 610.65B | -12.12% |
| 2017 | 694.83B | 34.40% |
The current Enterprise Value of Sumitomo Pharma Co., Ltd. (SMDPY) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
712.77B
5-year avg
644.90B
10-year avg
715.10B
Sumitomo Pharma Co., Ltd.’s Enterprise Value is greater than Viatris Inc. (34.82B), less than Daiichi Sankyo Company, Limited (5.41T), greater than Amneal Pharmaceuticals, Inc. (10.07B), greater than Hikma Pharmaceuticals PLC (6.63B), greater than Teva Pharmaceutical Industries Limited (61.67B), less than Shionogi & Co., Ltd. (3.02T), less than Ono Pharmaceutical Co., Ltd. (1.02T), less than Eisai Co., Ltd. (1.44T), less than Dr. Reddy's Laboratories Limited (1.20T), greater than Organon & Co. (10.73B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 34.82B | $22.08B | |
| 5.41T | $34.54B | |
| 10.07B | $6.95B | |
| 6.63B | $4.94B | |
| 61.67B | $48.77B | |
| 3.02T | $16.29B | |
| 1.02T | $7.08B | |
| 1.44T | $8.94B | |
| 1.20T | $12.30B | |
| 10.73B | $3.63B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sumitomo Pharma Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Sumitomo Pharma Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Sumitomo Pharma Co., Ltd.'s Enterprise Value?
What is the highest Enterprise Value for Sumitomo Pharma Co., Ltd. (SMDPY)?
What is the 3-year average Enterprise Value for Sumitomo Pharma Co., Ltd. (SMDPY)?
What is the 5-year average Enterprise Value for Sumitomo Pharma Co., Ltd. (SMDPY)?
How does the current Enterprise Value for Sumitomo Pharma Co., Ltd. (SMDPY) compare to its historical average?